Anthropic Collaborates with Six Institutions Including Bristol-Myers Squibb to Launch AI-Driven Drug Discovery and Develop Treatments for Rare Diseases
13 hour ago / Read about 0 minute
Author:小编   

On October 28, 2026, Anthropic announced a deep collaboration between its life sciences team and six institutions, including Bristol-Myers Squibb and Generate Biomedicines, to launch an autonomous drug discovery project. The initial focus is on a rare pediatric muscular atrophy, with Claude handling the majority of scientific and operational tasks. This collaboration aims to leverage AI technology to accelerate drug development for rare diseases, reduce research and development costs, improve efficiency, and enable early data sharing to advance global rare disease research.